INNING ONE
INNING ONE is a Seed, Series C+ and early-stage fund in the US investing in Healthcare and therapeutics.
- Stages
- Seed, Series C+, early-stage
- Sectors
- Healthcare, therapeutics
- Invests in
- US-wide
- Actively investing
- Yes
- Website
- inning1.com
Check size not disclosed
Thesis
Inning One Ventures is an early-stage venture capital firm based in New York, NY, that focuses on investing in and creating breakthrough biotechnology companies, with a primary emphasis on therapeutics. The firm targets innovative biotech startups with transformative potential, primarily within the United States. Their investment stage preference is described as 'later-stage early-stage,' and they have participated in Series C rounds. Their strategy involves leading or co-investing in deals, focusing on instrument types that support the development of novel therapeutics. As of February 2025, the firm has closed two funds and made three documented investments.
Common questions
Does INNING ONE invest at the Seed stage?
Yes. INNING ONE lists Seed, Series C+ and early-stage among the stages it invests in.
Where does INNING ONE invest?
INNING ONE invests in the US.